Lopinavir and ritonavir are both CYP3A4 substrates (Cvetkovic and Goa, 2003), so there is a potential for elevated levels following infection and inflammation-related down-regulation of CYP3A4 expression. The gene discussed is CYP3A4; the disease is infection.